OWC Pharmaceutical Research Corp. engages in the research and development of cannabis-based medical products for the treatment of myeloma and psoriasis. It focuses on the provision of consulting services and the development of a cannabis soluble tablet delivery system. The company was founded on March 7, 2008 and is headquartered in Ramat Gan, Israel.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company